Marshall Wace’s CME Group CME Stock Holding History

Marshall Wace’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$59.1K	Sell	200 -600	-75%	-$178K	﹤0.01%	2960
2025 Q4	$218K	Buy	+800	New	+$217K	﹤0.01%	2566

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marshall Wace's CME Position: Q1 2026 in Review

Marshall Wace increased its CME Group (CME) stake by 5,530% in Q1 2026, buying an estimated $235M and bringing the position to 804,218 shares worth $238M. The position accounts for 0.24% of the portfolio, ranked #59.

Marshall Wace first reported a position in CME in Q2 2014 and has held it in 31 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Marshall Wace held 804,218 shares of CME Group worth $238M as of Q1 2026.
Marshall Wace bought 789,933 CME Group shares in Q1 2026, an estimated $235M.
CME Group made up 0.24% of Marshall Wace's portfolio in Q1 2026, its #59 holding.
Marshall Wace first reported a position in CME Group in Q2 2014 and has held it in 31 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.